Back to Search
Start Over
HER2 expression and extensive molecular characterization of resected brain metastases from colorectal cancer: The HEROES study
- Source :
- Journal of Clinical Oncology. 40:2025-2025
- Publication Year :
- 2022
- Publisher :
- American Society of Clinical Oncology (ASCO), 2022.
-
Abstract
- 2025 Background: Brain metastases (BM) from primary colorectal cancer (prCRC) are rare (1-3%); few is known about CRC BM predictive factors, prognosticators and molecular pathways. High rate of HER2 amplification ( HER2+) in CRC with BM was previously described, being HER2+ overall rare in CRC (
- Subjects :
- Cancer Research
Oncology
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 40
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........592b5407e03c7d1725576a71a19e02bd
- Full Text :
- https://doi.org/10.1200/jco.2022.40.16_suppl.2025